stocknique

Profit takers today as expected,

Long
NASDAQ:ESPR   Esperion Therapeutics, Inc.
still bullish for a further GAP fill.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.